Overexpression of maelstrom promotes bladder urothelial carcinoma cell aggressiveness by epigenetically downregulating MTSS1 through DNMT3B

Downregulation of MTSS1 expression is an independent prognosticator in squamous cell carcinoma of the lung

(2015) G Kayser et al.   BRITISH JOURNAL OF CANCER

MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1

(2015) Kun Yao et al.   Diagnostic Pathology

p63 controls cell migration and invasion by transcriptional regulation of MTSS1

(2015) A Giacobbe et al.   ONCOGENE

Crystal Structure and Activity of the Endoribonuclease Domain of the piRNA Pathway Factor Maelstrom

(2015) Naoki Matsumoto et al.   Cell Reports

Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets

(2015) Fang Zheng et al.   PLoS Genetics

Overexpression of piRNA Pathway Genes in Epithelial Ovarian Cancer

(2014) Shu Ly Lim et al.   PLoS One

MTSS1 is a metastasis driver in a subset of human melanomas

(2014) Kirsten D. Mertz et al.   Nature Communications

Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes

(2013) Bárbara Mesquita et al.   BREAST CANCER RESEARCH AND TREATMENT

Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition by way of Akt/GSK-3β/Snail signaling

(2013) Lulu Liu et al.   HEPATOLOGY

Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA

(2013) Virginia López et al.   Journal of Translational Medicine

The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes

(2013) Y Cai et al.   ONCOGENE

Epidemiology and Risk Factors of Urothelial Bladder Cancer

(2012) Maximilian Burger et al.   EUROPEAN UROLOGY

ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for Urothelial Carcinoma—Neoadjuvant and Adjuvant Settings

(2012) Cora N. Sternberg et al.   EUROPEAN UROLOGY

The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer

(2011) H Yoshino et al.   BRITISH JOURNAL OF CANCER

piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells

(2011) Jia Cheng et al.   CANCER LETTERS

FGF-2 Regulates Cell Proliferation, Migration, and Angiogenesis through an NDY1/KDM2B-miR-101-EZH2 Pathway

(2011) Filippos Kottakis et al.   MOLECULAR CELL

MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma

(2011) H Fan et al.   ONCOGENE

Downregulation of metastasis suppressor 1(MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer

(2010) Ke Liu et al.   BMC CANCER

Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma

(2009) Dipen M. Maru et al.   CANCER

High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy

(2009) Li-Ru He et al.   INTERNATIONAL JOURNAL OF CANCER

Identification of a novel human cancer/testis gene MAEL that is regulated by DNA methylation

(2009) Ling Xiao et al.   MOLECULAR BIOLOGY REPORTS

Cytoplasmic Compartmentalization of the Fetal piRNA Pathway in Mice

(2009) Alexei A. Aravin et al.   PLoS Genetics

Refined mapping of loss of heterozygosity on 1q31.1-32.1 in sporadic colorectal carcinoma

(2008) Chong-Zhi Zhou et al.   WORLD JOURNAL OF GASTROENTEROLOGY